Interactions Between UPF1, ERFs, PABP and the Exon Junction Complex Suggest an Integrated Model for Mammalian NMD Pathways

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2008 Feb 8

PMID 18256688

Citations 191

Authors

Pavel V Ivanov

Niels H Gehring

Joachim B Kunz

Matthias W Hentze

Andreas E Kulozik

Affiliations

Soon will be listed here.

Abstract

Nonsense-mediated mRNA decay (NMD) represents a key mechanism to control the expression of wild-type and aberrant mRNAs. Phosphorylation of the protein UPF1 in the context of translation termination contributes to committing mRNAs to NMD. We report that translation termination is inhibited by UPF1 and stimulated by cytoplasmic poly(A)-binding protein (PABPC1). UPF1 binds to eRF1 and to the GTPase domain of eRF3 both in its GTP- and GDP-bound states. Importantly, mutation studies show that UPF1 can interact with the exon junction complex (EJC) alternatively through either UPF2 or UPF3b to become phosphorylated and to activate NMD. On this basis, we discuss an integrated model where UPF1 halts translation termination and is phosphorylated by SMG1 if the termination-promoting interaction of PABPC1 with eRF3 cannot readily occur. The EJC, with UPF2 or UPF3b as a cofactor, interferes with physiological termination through UPF1. This model integrates previously competing models of NMD and suggests a mechanistic basis for alternative NMD pathways.

Citing Articles

RNA anchoring of Upf1 facilitates recruitment of Dcp2 in the NMD decapping complex.

Ruiz-Gutierrez N, Dupas J, Auquier E, Barbarin-Bocahu I, Gaudon-Plesse C, Saveanu C Nucleic Acids Res. 2025; 53(5).

PMID: 40071934 PMC: 11897886. DOI: 10.1093/nar/gkaf160.

Cytoplasmic mRNA decay and quality control machineries in eukaryotes.

Dowdle M, Lykke-Andersen J Nat Rev Genet. 2025; .

PMID: 39870755 DOI: 10.1038/s41576-024-00810-1.

Identification of prognostic biomarkers of sepsis and construction of ceRNA regulatory networks.

Chen G, Zhang W, Wang C, Chen M, Hu Y, Wang Z Sci Rep. 2025; 15(1):2850.

PMID: 39843498 PMC: 11754875. DOI: 10.1038/s41598-024-78502-3.

Pleiotropic effects of PAB1 deletion: Extensive changes in the yeast proteome, transcriptome, and translatome.

Mangkalaphiban K, Ganesan R, Jacobson A PLoS Genet. 2024; 20(9):e1011392.

PMID: 39236083 PMC: 11407637. DOI: 10.1371/journal.pgen.1011392.

The impact of mRNA poly(A) tail length on eukaryotic translation stages.

Biziaev N, Shuvalov A, Salman A, Egorova T, Shuvalova E, Alkalaeva E Nucleic Acids Res. 2024; 52(13):7792-7808.

PMID: 38874498 PMC: 11260481. DOI: 10.1093/nar/gkae510.

References

Merkulova T, Frolova L, Lazar M, Camonis J, Kisselev L . C-terminal domains of human translation termination factors eRF1 and eRF3 mediate their in vivo interaction. FEBS Lett. 1999; 443(1):41-7. DOI: 10.1016/s0014-5793(98)01669-x. View

Chan W, Huang L, Gudikote J, Chang Y, Imam J, MacLean 2nd J . An alternative branch of the nonsense-mediated decay pathway. EMBO J. 2007; 26(7):1820-30. PMC: 1847659. DOI: 10.1038/sj.emboj.7601628. View

Tarpey P, Raymond F, Nguyen L, Rodriguez J, Hackett A, Vandeleur L . Mutations in UPF3B, a member of the nonsense-mediated mRNA decay complex, cause syndromic and nonsyndromic mental retardation. Nat Genet. 2007; 39(9):1127-33. PMC: 2872770. DOI: 10.1038/ng2100. View

Danckwardt S, Neu-Yilik G, Thermann R, Frede U, Hentze M, Kulozik A . Abnormally spliced beta-globin mRNAs: a single point mutation generates transcripts sensitive and insensitive to nonsense-mediated mRNA decay. Blood. 2002; 99(5):1811-6. DOI: 10.1182/blood.v99.5.1811. View

Durand S, Cougot N, Mahuteau-Betzer F, NGuyen C, Grierson D, Bertrand E . Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies. J Cell Biol. 2007; 178(7):1145-60. PMC: 2064650. DOI: 10.1083/jcb.200611086. View

Linde L, Boelz S, Neu-Yilik G, Kulozik A, Kerem B . The efficiency of nonsense-mediated mRNA decay is an inherent character and varies among different cells. Eur J Hum Genet. 2007; 15(11):1156-62. DOI: 10.1038/sj.ejhg.5201889. View

Kadlec J, Guilligay D, Ravelli R, Cusack S . Crystal structure of the UPF2-interacting domain of nonsense-mediated mRNA decay factor UPF1. RNA. 2006; 12(10):1817-24. PMC: 1581972. DOI: 10.1261/rna.177606. View

Pal M, Ishigaki Y, Nagy E, Maquat L . Evidence that phosphorylation of human Upfl protein varies with intracellular location and is mediated by a wortmannin-sensitive and rapamycin-sensitive PI 3-kinase-related kinase signaling pathway. RNA. 2001; 7(1):5-15. PMC: 1370068. DOI: 10.1017/s1355838201000127. View

Maquat L . Nonsense-mediated mRNA decay: splicing, translation and mRNP dynamics. Nat Rev Mol Cell Biol. 2004; 5(2):89-99. DOI: 10.1038/nrm1310. View

10.

Gehring N, Kunz J, Neu-Yilik G, Breit S, Viegas M, Hentze M . Exon-junction complex components specify distinct routes of nonsense-mediated mRNA decay with differential cofactor requirements. Mol Cell. 2005; 20(1):65-75. DOI: 10.1016/j.molcel.2005.08.012. View

11.

Weng Y, Czaplinski K, Peltz S . Identification and characterization of mutations in the UPF1 gene that affect nonsense suppression and the formation of the Upf protein complex but not mRNA turnover. Mol Cell Biol. 1996; 16(10):5491-506. PMC: 231549. DOI: 10.1128/MCB.16.10.5491. View

12.

Gehring N, Neu-Yilik G, Schell T, Hentze M, Kulozik A . Y14 and hUpf3b form an NMD-activating complex. Mol Cell. 2003; 11(4):939-49. DOI: 10.1016/s1097-2765(03)00142-4. View

13.

Amrani N, Dong S, He F, Ganesan R, Ghosh S, Kervestin S . Aberrant termination triggers nonsense-mediated mRNA decay. Biochem Soc Trans. 2005; 34(Pt 1):39-42. DOI: 10.1042/BST20060039. View

14.

Fukuhara N, Ebert J, Unterholzner L, Lindner D, Izaurralde E, Conti E . SMG7 is a 14-3-3-like adaptor in the nonsense-mediated mRNA decay pathway. Mol Cell. 2005; 17(4):537-47. DOI: 10.1016/j.molcel.2005.01.010. View

15.

Hosoda N, Kobayashi T, Uchida N, Funakoshi Y, Kikuchi Y, Hoshino S . Translation termination factor eRF3 mediates mRNA decay through the regulation of deadenylation. J Biol Chem. 2003; 278(40):38287-91. DOI: 10.1074/jbc.C300300200. View

16.

Hauryliuk V, Zavialov A, Kisselev L, Ehrenberg M . Class-1 release factor eRF1 promotes GTP binding by class-2 release factor eRF3. Biochimie. 2006; 88(7):747-57. DOI: 10.1016/j.biochi.2006.06.001. View

17.

Kunz J, Neu-Yilik G, Hentze M, Kulozik A, Gehring N . Functions of hUpf3a and hUpf3b in nonsense-mediated mRNA decay and translation. RNA. 2006; 12(6):1015-22. PMC: 1464862. DOI: 10.1261/rna.12506. View

18.

Palacios I, Gatfield D, St Johnston D, Izaurralde E . An eIF4AIII-containing complex required for mRNA localization and nonsense-mediated mRNA decay. Nature. 2004; 427(6976):753-7. DOI: 10.1038/nature02351. View

19.

Alkalaeva E, Pisarev A, Frolova L, Kisselev L, Pestova T . In vitro reconstitution of eukaryotic translation reveals cooperativity between release factors eRF1 and eRF3. Cell. 2006; 125(6):1125-36. DOI: 10.1016/j.cell.2006.04.035. View

20.

Kobayashi T, Funakoshi Y, Hoshino S, Katada T . The GTP-binding release factor eRF3 as a key mediator coupling translation termination to mRNA decay. J Biol Chem. 2004; 279(44):45693-700. DOI: 10.1074/jbc.M405163200. View